Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK1 | P23458 | 20/20 | 0.47 |
| ▸ | TYK2 | P29597 | 7/20 | 0.42 |
| ▸ | JAK3 | P52333 | 7/20 | 0.42 |
| ▸ | JAK2 | O60674 | 6/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2280027 | 0.87 | JAK1 (0.49) | JAK1TYK2JAK3JAK2CYP3A4 | |
| SCHEMBL2270958 | 0.82 | JAK1 (0.42) | JAK1TYK2JAK3JAK2CYP3A4 | |
| SCHEMBL2282949 | 0.82 | JAK1 (0.56) | JAK1TYK2JAK3JAK2CYP3A4 | |
| SCHEMBL2223799 | 0.82 | JAK1 (0.56) | JAK1TYK2JAK3JAK2CYP3A4 | |
| SCHEMBL2365035 | 0.81 | JAK1 (0.70) | JAK1TYK2JAK3JAK2CYP3A4 | |
| SCHEMBL2274431 | 0.81 | JAK1 (0.46) | JAK1TYK2JAK3JAK2CYP3A4 | |
| SCHEMBL2278579 | 0.80 | JAK1 (0.47) | JAK1TYK2JAK3JAK2CYP3A4 | |
| SCHEMBL2277422 | 0.80 | JAK1 (0.47) | JAK1TYK2JAK3JAK2CYP3A4 | |
| SCHEMBL2282844 | 0.79 | JAK1 (0.43) | JAK1TYK2JAK3JAK2CYP3A4 | |
| SCHEMBL2281917 | 0.78 | JAK1 (0.59) | JAK1TYK2JAK3JAK2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2523957-A1 | TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | F. Hoffmann-La Roche AG (CH) | 2012-11-21 | — | — | EP | disclosed |
| WO-2011086053-A1 | TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | F. HOFFMANN-LA ROCHE AG (CH) | 2011-07-21 | — | — | WO | disclosed |